Corrigendum to "Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV" [Bioorg. Med. Chem. 17 (2009) 5791] (DOI:10.1016/j.bmc.2009.07.019);Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 16, 2009, Pages 5791-5795

  Abdulkadir Coban T ^a   Beydemir, Şükrü ^b   Gücin, Ilhami ^b   Ekinci, Deniz ^b   Innocenti, Alessio ^c   Vullo, Daniela ^c   Supuran, Claudiu T ^c  

^a ERZINCAN UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbonic anhydrase; Enzyme activator; Isozymes I XIV; Piperazine; Proton shuttling; Sildenafil citrate

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE 6; CARBONATE DEHYDRATASE 7; CARBONATE DEHYDRATASE 8; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; CARBONIC ANHYDRASE 14; ISOENZYME; NITRITE; PHOSPHODIESTERASE V; PIPERAZINE; SILDENAFIL; TADALAFIL; UNCLASSIFIED DRUG; VARDENAFIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT;

ANIMALIA; MAMMALIA; RATTUS;

EID: 68149136447     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.11.040     Document Type: Erratum

References (49)

1. Andersson K.E. Pharmacol. Rev. 53 (2005) 417
2. Cheitlin MD., Hutter A.M., Brindis R.G., Ganz P., and Kaul S. Circulation 99 (1999) 168
3. Sung B.J., Hwang K.Y., Jeon Y.H., Lee J.I., Heo Y.S., Kim J.H., Moon J., Yoon J.M., Hyun Y.L., Kim E., Eum S.J., Park S.Y., Lee J.O., Lee T.G., Ro S., and Cho J.M. Nature 425 (2003) 98
4. Hassan M.A.H., and Ketat A.F. BMC Clin. Pharm. 5 (2005) 1471
5. Supuran C.T., Mastrolorenzo A., Barbaro G., and Scozzafava A. Curr. Pharm. Des. 12 (2006) 3459
6. Supuran C.T., and Winum J.Y. Introduction to Zinc Enzymes as Drug Targets. In: Supuran C.T., and Winum J.Y. (Eds). Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications (2009), Wiley, Hoboken 3-12
7. Supuran C.T. Bacterial Zinc Proteases as Orphan Targets. In: Supuran C.T., and Winum J.Y. (Eds). Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications (2009), Wiley, Hoboken 675-704
8. Supuran C.T., and Scozzafava A. Bioorg. Med. Chem. 15 (2007) 4336
9. Supuran C.T. Nat. Rev. Drug Disc. 7 (2008) 168
10. Supuran C.T. Carbonic Anhydrases as Drug Targets-General Presentation. In: Supuran C.T., and Winum J.Y. (Eds). Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications (2009), Wiley, Hoboken 15-38
11. Beydemir S., and Gülçin I. J. Enzyme Inhib. Med. Chem. 19 (2004) 193
12. Beydemir S., Çiftçi M., Kufrevioglu O.I., and Büyükokuroǧlu M.E. Biol. Pharm. Bull. 25 (2002) 966
13. Temperini C., Scozzafava A., and Supuran C.T. Curr. Pharm. Des. 14 (2008) 708
14. Briganti F., Mangani S., Orioli P., Scozzafava A., Vernaglione G., and Supuran C.T. Biochemistry 36 (1997) 10384
15. Ilies M., Scozzafava A., and Supuran C.T. Carbonic Anhydrase Activators. In: Supuran C.T., Scozzafava A., and Conway J. (Eds). Carbonic Anhydrase-Its Inhibitors and Activators (2004), CRC Press, Boca Raton (FL), USA 317-352
16. Supuran C.T., and Scozzafava A. Activation of Carbonic Anhydrase Isozymes. In: Chegwidden W.R., Carter N., and Edwards Y. (Eds). The Carbonic Anhydrases-New Horizons (2000), Birkhauser Verlag, Basel, Switzerland 197-219
17. Supuran C.T. Therapy 4 (2007) 355
18. Innocenti A., Hilvo M., Parkkila S., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 19 (2009) 3430
19. Supuran C.T. Curr. Pharm. Des. 14 (2008) 641
20. Temperini C., Cecchi A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 18 (2008) 2567
21. Pastorekova S., Parkkila S., Pastorek J., and Supuran C.T. J. Enzyme Inhib. Med. Chem. 19 (2004) 199
22. Supuran C.T. Curr. Top. Med. Chem. 7 (2007) 825
23. Scozzafava A., Mastrolorenzo A., and Supuran C.T. Exp. Opin. Ther. Pat. 16 (2006) 1627
24. Supuran C.T., Scozzafava A., and Casini A. Med. Res. Rev. 23 (2003) 146
25. Parkkila S., Vullo D., Puccetti L., Parkkila A.K., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem Lett. 16 (2006) 3955
26. Vullo D., Nishimori I., Innocenti A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 17 (2007) 1336
27. Vullo D., Innocenti A., Nishimori I., Scozzafava A., Kaila K., and Supuran C.T. Bioorg. Med. Chem Lett. 17 (2007) 4107
28. Nishimori I., Onishi S., Vullo D., Innocenti A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. 15 (2007) 5351
29. Temperini C., Scozzafava A., Vullo D., and Supuran C.T. Chemistry 12 (2006) 7057
30. Temperini C., Innocenti A., Scozzafava A., Mastrolorenzo A., and Supuran C.T. Bioorg. Med. Chem. Lett. 17 (2007) 628
31. Vullo D., Innocenti A., Nishimori I., Scozzafava A., Kaila K., and Supuran C.T. Bioorg. Med. Chem. Lett. 17 (2007) 4107
32. Pastorekova S., Vullo D., Nishimori I., Scozzafava A., Pastorek J., and Supuran C.T. Bioorg. Med. Chem. 16 (2008) 3530
33. Vullo D., Nishimori I., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. 16 (2008) 4303
34. Hilvo M., Baranauskiene L., Salzano A.M., Scaloni A., Matulis D., Innocenti A., Scozzafava A., Monti S.M., Di Fiore A., De Simone G., Lindfors M., Janis J., Valjakka J., Pastorekova S., Pastorek J., Kulomaa M.S., Nordlund H.R., Supuran C.T., and Parkkila S. J. Biol. Chem. 283 (2008) 27799
35. Maresca A., Temperini C., Vu H., Pham N.B., Poulsen S.A., Scozzafava A., Quinn R.J., and Supuran C.T. J. Am. Chem. Soc. 131 (2009) 3057
36. Temperini C., Innocenti A., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. 16 (2008) 8373
37. Cheitlin M.D. Cardiol. Rev. 7 (1999) 173
38. Krenzelok E.P. Clin. Toxicol. 38 (2000) 645
39. Nair S.K., Ludwig P.A., and Christianson D.W. J. Am. Chem. Soc. 116 (1994) 3659
40. Innocenti A., Vullo D., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. Lett. 18 (2008) 1583
41. Innocenti A., Vullo D., Scozzafava A., and Supuran C.T. Bioorg. Med. Chem. 16 (2008) 7424
42. Innocenti A., Hilvo M., Scozzafava A., Parkkila S., and Supuran C.T. Bioorg. Med. Chem. Lett. 18 (2008) 3593
43. Bayram E., Senturk M., Kufrevioglu O.I., and Supuran C.T. Bioorg. Med. Chem. 16 (2008) 9101
44. Mincione F., Scozzafava A., and Supuran C.T. Antiglaucoma Carbonic Anhydrase Inhibitors as Ophthalomologic Drugs. In: Supuran C.T., and Winum J.Y. (Eds). Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications (2009), Wiley, Hoboken 139-154
45. Khalifah R.G. J. Biol. Chem. 246 (1971) 2561
46. Arslan O., Nalbantoǧlu B., Demir N., Özdemir H., and Küfrevioǧlu O.I. Tr. J. Med. Sci. 26 (1996) 163
47. Çiftçi M., Beydemir S., Yilmaz H., and Bakan E. Pol. J. Pharm. 54 (2002) 275
48. Gülçin I., Beydemir S., and Büyükokuroǧlu M.E. Biol. Pharm. Bull. 27 (2004) 613
49. Rickli E.E., Ghazanfar S.A.S., Gibbons B.H., and Edsall J.T. J. Biol. Chem. 239 (1964) 1065